Maccura Biotechnology Co.Ltd (SHE:300463)

Market Cap	7.02B
Revenue (ttm)	2.34B
Net Income (ttm)	-40.88M
Shares Out	604.67M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	26.79
Dividend	0.10 (0.90%)
Ex-Dividend Date	May 28, 2025

Volume	5,252,232
Average Volume	6,272,822
Open	11.58
Previous Close	11.57
Day's Range	11.41 - 11.64
52-Week Range	10.90 - 17.31
Beta	0.23
RSI	32.28
Earnings Date	Oct 24, 2025

About SHE:300463

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such as digital PCR and extraction systems, and PCR kits; urinalysis analyzer systems and semi-automatic urine analyzers; and hemostasis solutions, including...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1994
• Employees: 3,472
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300463

Financial Performance

In 2024, SHE:300463's revenue was 2.55 billion, a decrease of -11.98% compared to the previous year's 2.90 billion. Earnings were 126.81 million, a decrease of -59.44%.